Nuformix
Dr Julian Gilbert, Non-Executive Director, has more than 30 years of commercial and technical experience in the pharmaceutical industry gained at a number of companies including Chiroscience Plc, Mundipharma International Limited, British Technology Group plc (BTG) and Smith Kline & French (now GlaxoSmithKline plc).
Most recently, Julian was Co-founder and CEO of Acacia Pharma Group plc (Acacia), raising £100m in private and public funding and leading its flotation on Euronext in 2018. Prior to Acacia, he was co-founder and Commercial Director of Arakis Limited which was sold to Sosei in 2005 for £107 million. Julian has worked in business development since 1992 and has led multiple business development projects.
Julian has a degree in pharmacy and a PhD in pharmaceutics, both from the University of Nottingham.
Committees: Julian is Chairman of the Nomination Committee and a member of the Remuneration and Audit Committees.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nuformix
Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing.